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ABSTRACT 
The lipase catalysed kinetic resolution of three trans-1-(2-hydroxycyclohexyl)-indoles in 
both batch and continuous-flow systems is reported. Ring opening of cyclohexene oxide by 
the corresponding indole followed by enzymatic acylation with vinyl acetate resulted in novel, 
highly enantioenriched indole-substituted cyclohexanols and cyclohexyl acetates. The effect 
of the temperature on enantiomeric ratio (E) and productivity (specific reaction rate, rflow) in 
the continuous-flow mode acylation was studied at analytical scale in the 0–70°C range. 
Preparative scale kinetic resolution of the three indole derivatives was performed in mixed 
continuous- and recirculation-flow mode resulting in almost complete conversion and good to 
excellent enantiomeric purity of the products. 
 
Keywords: Lipase, heterocyclic secondary alcohol, kinetic resolution, continuous-flow 
biotransformation, enantiomer selectivity, temperature effect 
1. Introduction 
Indole derivatives are important as natural compounds and utilized not only in the 
pharmaceutical industry but also used in agrochemicals (e.g. fungicides, herbicides), in 
dietary supplements and nutraceuticals, colorants industry or fragrance industry.
1,2
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indole skeleton is a prevalent building block of numerous pharmaceutical agents. One of the 
reasons which make indole ring quite indispensable is the wide range of biological effects: 
e.g. the amino-acid tryptophan, the hormones serotonin
3
 and melatonin
4
, the psychotropic 
drugs LSD,
5
 bufotenine and psilobycin
6
 and the antitumor agent vinblastine.
7,8
 
Ring opening of epoxides with indole derivatives under neutral or basic conditions follows 
an SN2 mechanism and provide trans-1,2-disubstituted products.
9
 These reactions usually 
require a strong base or acid,
10
 high temperature
11
 or high pressure.
12
 Recently, epoxy ring 
opening under microwave condition
13,14
 or in continuous-flow reactor
15
 have been reported. 
Due to the ever growing need of the pharmaceutical and fine chemicals industries for 
enantiomerically pure compounds, the armoury of novel stereoselective synthetic methods is 
continuously expanding. The use of biocatalysts for these purposes grows with this 
expansion
16-19
 since biocatalysis often requires milder conditions in stereoselective reaction 
than chemocatalysis. Hydrolases, especially lipases are among the most often used enzymes 
for synthetic purposes.
20
 Lipases have been used for numerous stereoselective 
biotransformations
21-26
 such as kinetic resolution (KR)
20,27
, deracemisation and dynamic 
kinetic resolution (DKR)
30
 due to their high regio-, chemo- and enantioselectivity, high 
stability, compatibility of organic solvents, wide substrate range, and because they do not 
need co-factors. Lipases – either in their native form or tailored by genetic engineering – are 
ideally suited for industrial applications,
17,28
 preferably in their immobilised forms to enable 
recycling. Alcohols and amines are the most thoroughly investigated substrates in KR and 
DKR.
29-38
 The production of chiral alcohols brought in 2002 more than 7 billion dollars in 
revenues worldwide and this was forecasted to be 14.9 billion dollars by the year 2009.
39
 
Although a tremendous number of biocatalytic reactions have been studied,
16-18,20-26
 the 
operational parameters reported for most of them seem to be rather suboptimal. Therefore, 
there is still much room for optimization promoting thereby faster transfer to an industrial 
scale. Even today, most of biosynthetic operations are performed as a fixed, batch based 
single step procedure. Although continuous processes offer several advantages – such as 
facile automation, reproducibility and safety – the benefits of the flow-through approach40-45 
have not been fully exploited so far. 
Because immobilized biocatalysts are recyclable, storable and easy to handle, 
immobilization is an important trend in biotechnology.
46-51
 Selectivity, specificity, catalytic 
activity and enzyme stability are key factors affecting the efficiency of biocatalysts.
16-18,20-26
 
Immobilization can often improve these key properties
46-51
 and also enabling the use of 
biocatalysts under continuous-flow conditions.
19
  
Among the factors influencing selectivity, catalytic activity and stability of the biocatalysts 
under continuous-flow conditions, temperature effects are the most important. In enzyme-
catalysed reactions, increasing temperature generally decreases selectivity.
52-62
 In a few 
studies, however, enhanced selectivity with increasing temperature,
63,64
 or a maximum of 
enantioselectivity at a certain temperature,
38,65 
or even indifference to temperature was 
found.
66
 In most of the quoted examples, the enzyme-catalysed reactions were carried out in 
batch mode (in stirred or shaken flasks) and only a few studies on the temperature effects on 
lipase-catalysed KRs were performed in continuous-flow mode so far.
19,38,65
 
Herein the synthesis and lipase-catalysed kinetic resolutions of racemic 1-(2-
hydroxycyclohexyl)indoles (rac-2a–c) are reported in both batch and continuous-flow 
systems (Scheme 1). According to our best knowledge, these are the first KRs of the already 
known (rac-2a) and of the novel trans-1-(2-hydroxycyclohexyl)indoles (rac-2b and rac-2c). 
The effect of temperature on enantiomer selectivity was also investigated under continuous-
flow conditions. 
 
 
Scheme 1. Synthesis and kinetic resolution of secondary alcohols (rac-2a–c) in batch (A) and in continuous-flow mode (B) 
2. Results and Discussion 
For this study, three indole-substituted cyclohexanols (rac-2a–c) were synthesised by a 
slight modification of the process described for the preparation of rac-2a (Scheme 1)
67
 i.e. the 
ring opening of cyclohexene oxide with the corresponding indole derivate (1a–c) using NaH 
(1 equiv.) in dry DMF. The indoles (1b and 1c) bearing slightly electron donating substituents 
showed similar reactivity as the unsubstituted indole (1a) providing the new indole-
substituted trans-cyclohexanols (rac-2b and rac-2c) in excellent yields.
 
2.1. Kinetic resolution of secondary alcohols (rac-2a–c) in batch mode 
KRs of the indole-substituted secondary alcohols (rac-2a–c) were carried out with 23 
different lipases by acylation with vinyl acetate (Table 1).  
 
Table 1. Lipase-catalysed kinetic resolution of secondary alcohols (rac-2a–c) by acylation with vinyl acetate in batch mode 
(30°C, shake flask). 
Entry Substrate Enzyme c (%)
a
 ee(R,R)-3a (%)
b
 E
c
 rbatch (µmol g
-1
 h
-1
) 
Panel A
d
      
1 rac-2a CaLB N435 49.9 ›99.9 »200 32.6 
2 rac-2a Lipobond PS 47.2 ›99.9 »200 30.8 
3 rac-2a Lipozyme TLIM 40.2 ›99.9 »200 26.2 
4 rac-2a Lipozyme MmL 38.7 ›99.9 »200 25.3 
5 rac-2a Amano AK 37.0 ›99.9 »200 24.1 
6 rac-2a CaLA G250P 25.1 99.8 »200 16.4 
7 rac-2a CaLA T2-150 14.7 99.6 »200 9.6 
8 rac-2a MpL G250P 13.9 99.9 »200 9.0 
9 rac-2a MpL G250O 11.1 99.9 »200 7.2 
10 rac-2a CaLB G250P 9.4 99.9 »200 6.2 
11 rac-2a PaL G250P 8.6 99.8 »200 5.6 
Panel B
e
      
12 rac-2b CaLB N435 41.2 ›99.9 »200 37.6 
13 rac-2b Lipobond PS 27.7 ›99.9 »200 25.0 
14 rac-2b Lipozyme TLIM 27.4 ›99.9 »200 25.0 
15 rac-2b Lipozyme MmL 24.1 ›99.9 »200 21.7 
16 rac-2b CaLB G250P 12.9 99.9 »200 11.9 
17 rac-2b Amano AK 9.0 99.9 »200 8.1 
18 rac-2b Amano M 6.5 99.9 »200 5.9 
19 rac-2b Amano PS 5.5 99.8 »200 5.0 
Panel C
e
      
20 rac-2c Lipozyme TLIM 44.9 ›99.9 »200 38.6 
21 rac-2c CaLB N435 38.7 ›99.9 »200 33.0 
22 rac-2c Lipozyme MmL 34.4 ›99.9 »200 29.1 
23 rac-2c Lipobond PS 33.5 ›99.9 »200 28.5 
24 rac-2c Amano AK 27.0 99.9 »200 22.8 
25 rac-2c CaLB G250P 13.7 99.9 »200 11.7 
26 rac-2c CaLA G250P 10.6 99.9 »200 9.0 
27 rac-2c CrL 7.3 99.9 »200 6.2 
28 rac-2c Amano PS 7.2 99.8 »200 6.1 
29 rac-2c CaLA T2-150 6.9 99.8 »200 5.9 
a Results are shown only for reactions with c ›5%. 
b Enantiomeric excess of ester (ee(R,R)-3a–c) was determined by chiral GC. 
c Enantiomeric ratio (E) was calculated from c and ee(R,R)-3a–c.
68 For simplicity, E values calculated above 500  were given as 
»200. 
d Reaction time 72 h. 
e Reaction time 48 h. 
 
The KRs were performed in hexane–tert-butyl methyl ether (2:1) at 30°C using various 
forms of the lipases (such as lyophilised powder, adsorbed on surface-modified silica gel, 
acrylic or ion-exchange resins, as well as covalently attached to acrylic resin). In the KR of 
the unsubstituted indole derivative rac-2a, excellent enantiomer selectivity (E »200) was 
observed with most of the biocatalysts (Table 1, Panel A). Enantiomeric excess of the product 
(R,R)-3a was predominantly at least 99.9%. Moreover, this could be realised at conversions of 
35% or above with five lipase preparations while KR was almost complete (nearly 50% 
conversion) with CaLB N435 or Lipobond PS. Although in the case of CaLA or CaLB 
significant differences were found in selectivity and activity due to the nature of the 
hydrophobic grafting of the silica gel supports,
69
 in the case of MpL no significant differences 
were observed between the forms adsorbed onto phenyl- and octyl-grafted silica gels (Entries 
8 and 9, respectively).  
In the case of several other lipases, however, remarkable variations were found when the 
same lipase was immobilised by different methods. Such phenomena were observed when 
CaLA was adsorbed either on phenyl-grafted silica gel or attached covalently to porous 
polymethacrylate beads (Entries 6 and 7, respectively) or when CaLB was adsorbed on acrylic 
resin or on phenyl modified silica gel (Entries 1 and 10, respectively). In the case of CaLA, 
the phenyl silica-adsorbed form showed both higher activity and selectivity (Entry 6) than the 
other form (Entry 7). The high enantiomer selectivity of CaLA with rac-2a (E »200) is also 
noteworthy, because in other KRs of various secondary alcohols this lipase was not 
particularly selective.
36,69,70
 With CaLB, adsorbed on acrylic resin (Entry 1) was much more 
active but similarly selective than when adsorbed onto phenyl silica (Entry 10). Surprisingly, 
the lipase from Burkholderia cepacia exhibited no activity as lyophilised powder (Amano PS) 
or when adsorbed on octyl-grafted silica gel (data not shown in Table 1), whereas excellent 
enantiomeric excess values and conversions were observed when it was covalently attached to 
acrylic resin (Entry 2). 
The KRs of rac-2b (Table 1, Panel B) proceeded quite similarly to those of rac-2a. The 
best selectivity and activity was achieved with the same four biocatalysts (CaLB N435, 
Lipobond PS, Lipozyme TLIM and Lipozyme MmL; Entries 12–15) as with of rac-2a. 
Although, each biocatalysts showed somewhat lower activity compared to the series with rac-
2a, excellent enantiomer selectivity was maintained (E »200; Entries 12–15).  
Amano AK proved to be much less active with rac-2b (c=9.0% in Entry 5) than with rac-
2a (c=37.0% in Entry 17), but its high selectivity (E »200 and ee(R,R)-3a ≥99.9 %) was retained. 
Surprisingly, CaLA and MpL which were active on rac-2a (Entries 6–9) did not exhibit any 
notable activity on rac-2b. On the other hand, the lyophilised lipases Amano M and Amano 
PS which were apparently inactive with rac-2a catalysed the acylation of rac-2b (Entries 18 
and 19). These results indicated that a substituent of moderate size at position 3 of the indole 
moiety in 2b did not cause much variation among the various lipases concerning the relative 
binding orientation of the enantiomers of 2b as compared to those of 2a but influenced only 
their binding ability. 
The KR results with rac-2c are shown in Table 1 (Panel C). The fact that Lipozyme TLIM 
was significantly more active (Entry 20) than CaLB N435 (Entry 21) indicated that 5-MeO-
substitution of the indole moiety requires a quite different steric environment within the active 
site than the one necessary for the two previously discussed 2-(1-indolyl)cyclohexanols (rac-
2a–b). In the case of CrL, the different steric requirement for efficient catalysis in the KR of 
rac-2c was also obvious, because this lipase was active only in the KR of the 5-MeO-
substituted substrate. It showed moderate activity and excellent enantiomer selectivity (Entry 
27) but was apparently inactive with the other two cyclohexanols (rac-2a–b). Although CaLB 
was not the most active biocatalyst in KR of rac-2c, but demonstrated a high degree of 
enantiomer selectivity (Entries 21 and 25). This applied to both forms of CaLA in KRs of rac-
2c (Entries 26 and 29). Similarly, excellent selectivities could be achieved with Lipozyme 
MmL, Lipobond PS, Amano AK and Amano PS at lower conversions (Entries 22, 23, 24 and 
28, respectively). 
2.2. Continuous-flow kinetic resolution of secondary alcohols (rac-2a–c) 
KRs in continuous-flow mode were carried out in a multicolumn reactor system (Figure 1) 
assembled within a multicolumn metal block reactor (Figure 1B), an external cooling-heating 
thermostat, a temperature control unit and an isocratic HPLC pump. The reactions in 
continuous-flow mode (Figure 1C) were performed in stainless steel packed bed CatCart
TM
 
columns filled with the proper biocatalyst.  
 
Figure 1. A multicolumn continuous-flow reactor system (A). The multicolumn reactor block (B) and the scheme of the KRs 
in the continuous-flow reactor (C: rac-2a–c) are also shown. 
Selection of biocatalysts to study the KRs of rac-2a–c in continuous-flow mode was based 
on the results of KRs of rac-2a–c in batch experiments. Thus, continuous-flow KRs were 
investigated using Amano AK, CaLA Dv250P, CaLB N435, Lipobond PS, Lipozyme MmL 
and Lipozyme TLIM for rac-2a, further CaLB N435, Lipobond PS, Lipozyme MmL and 
Lipozyme TLIM for rac-2b and rac-2c. A solution of rac-2a–c and vinyl acetate in hexane–
tert-butyl methyl ether (2:1) was pumped through the lipase filled column thermostated to a 
certain temperature (10°C steps in the 0°C to 60°C or 0°C to 70°C range) at a flow rate of 0.2 
mL/min. Samples were taken when reaching the stationary state (30 min after starting a new 
run) and analysed by GC (Section 4.2.). 
 
Figure 2. Temperature dependent biocatalytic properties (E, ee and rflow) of various lipase biocatalysts in the kinetic 
resolution of rac-2a by acylation with vinyl acetate in a continuous-flow reactor. Unfilled markers and dashed lines are from 
GC measurements with the minor enantiomers under detection limits; see Section 4.2. 
The results of KRs of rac-2a in continuous-flow mode are shown in Figure 2. In 
accordance with the KRs in batch mode, the different biocatalysts exhibited diverse 
productivity (specific reaction rate, rflow) but less variable and high enantiomer selectivity (E 
values from ›100 to »200, between 20 and 60°C). All active biocatalysts behaved similarly 
and their productivity increased exponentially between 0 and 70°C, except for Lipozyme 
MmL (where rflow stopped increasing at around 50°C). This indicated the thermostability of all 
investigated lipases, except of Lipozyme MmL up to 70°C under the investigated continuous-
flow conditions. Lipozyme TLIM showed the highest productivity (0–40°C) while Amano 
AK was the least active in KR of rac-2a in continuous-flow mode. Lipobond PS was the most 
selective biocatalyst in the ambient temperature regime between 20 and 50°C (E »200 and 
ee(R,R)-3a from 99.8 to ›99.9%) and even at high temperature such as 70°C (E »200 and ee(R,R)-
3a ›99.9%). Although CaLB N435 did not show notable productivity in the lower temperature 
range (below 20°C), its productivity increased drastically from 30°C and it was the most 
active catalyst above 50°C. Importantly, it exhibited also excellent selectivity at 70°C (E »200 
and ee(R,R)-3a ›99.9%). CaLA Dv250P behaved differently than the other biocatalysts. In a 
wide range of temperature (0–60°C) its productivity (rflow) increased only moderately but rflow 
almost tripled when the temperature rose from 60°C to 70°C. CaLA Dv250P was the only 
catalyst with significant drop in selectivity at high temperature: ee(R,R)-3a dropped from 99.7% 
at 60°C to 99.4% at 70°C. 
 
Figure 3. Temperature dependent biocatalytic properties (E, ee and rflow) of various lipase biocatalysts in kinetic resolution of 
rac-2b by acylation with vinyl acetate in a continuous-flow reactor. Unfilled markers and dashed lines are from GC 
measurements with the minor enantiomers under detection limits; see Section 4.2. 
Those four lipases (CaLB N435, Lipobond PS, Lipozyme TLIM and Lipozyme MmL) 
which showed the highest activities in batch mode KRs of the 3-methyl-substituted-indole 
substrate (rac-2b, Entries 12–15 in Table 1) were further studied at various temperatures in 
the continuous-flow mode KRs of rac-2b (Figure 3). Investigations of the two most active 
ones (CaLB N435 and Lipobond PS) between 0–70°C and the further two (Lipozyme TLIM 
and Lipozyme MmL) between 0–60°C (Figure 3) showed quite similar temperature-
dependent biocatalytic behaviour to those found in the KRs of rac-2a (Figure 2). At the low 
temperature range (0–20°C) CaLB N435 was almost inactive in the KR of rac-2b, while in 
the range of 20–70°C exponential ascend of rflow was observed. CaLB N435 and Lipozyme 
TLIM were the most selective lipases in the KR of rac-2b above 50°C (E »200 and ee(R,R)-3b 
›99.9%). Lipobond PS exhibited lower but still exponentially increasing productivity from 
0°C to 70°C with excellent selectivity at high temperature (E »200 and ee(R,R)-3b ›99.9% at 
70°C). Thermostability of Lipozyme MmL proved to be poor in the continuous-flow KR of 
rac-2b as well, because rflow did not increase above 50°C. 
 
Figure 4. Temperature dependent biocatalytic properties (E, ee and rflow) of various lipase biocatalysts in kinetic resolution of 
rac-2c by acylation with vinyl acetate in a continuous-flow reactor. Unfilled markers and dashed lines are from GC 
measurements with the minor enantiomers under detection limits; see Section 4.2. 
Again, the four lipases (CaLB N435, Lipobond PS, Lipozyme TLIM and Lipozyme MmL) 
showing the highest activity in batch mode KRs of the 5-methoxy-substituted-indole substrate 
(rac-2c, Entries 20–23 in Table 1) were studied at various temperatures in the continuous-
flow mode KRs as well (Figure 4). In this case, the two most active biocatalysts (Lipozyme 
TLIM and CaLB N435) were studied between 0–70°C and the further two (Lipobond PS and 
Lipozyme MmL) only between 0–60°C (Figure 3). In accordance with the results in batch 
mode KRs (Table 1, Panel C) the highest productivity in the whole temperature range (0–
70°C) was achieved with Lipozyme TLIM combined with excellent selectivity [E »200 and 
monotonically increasing ee(R,R)-3c from 99.6% (10°C) to ›99.9% (70°C)]. Contrarily to the 
KRs of rac-2a or rac-2b, where CaLB N435 was the most active biocatalyst in the high 
temperature range of 50–70°C, its productivity remained lower than that of Lipozyme TLIM 
in the KRs of rac-2b at any temperature covered. Although Lipozyme MmL showed good 
enantiomer selectivity in the ambient temperature range (E from ›200 to »200 and ee(R,R)-3c 
from 99.6% to 99.8% between 20–60°C), its applicability is limited due to the partial 
deactivation of the enzyme above 50°C. In contrast to the KRs of rac-2a, the lowest 
productivity was obtained with Lipobond PS although selectivity with good above 50°C (E 
»200 and ee(R,R)-3c ›99.7%). 
In conclusion, generally higher productivity can be obtained at the high temperature range 
(50–70°C) with all the investigated biocatalysts but Lipozyme MmL. Enantiomeric selectivity 
of the lipase-catalysed KRs of rac-2a–c did not drop with increasing temperature due to the 
fact that trans-1-(2-hydroxycyclohexyl)-indoles (rac-2a–c) are rather bulky and 
conformationally rigid substrates. 
2.3. Preparation of enantiomerically enriched alcohols (2a–c) and acetates (3a–c) in 
flow mode at preparative scale  
The crucial issue in the development of a preparative scale method is finding the optimal 
temperature at which productivity, selectivity and lifetime of the enzyme are balanced.. In 
general, productivity is increasing with increasing temperature, although at higher 
temperature lifetime of the biocatalyst may suffer decrease. Since the best overall 
performance in the continuous-flow KR of all the three substrates (rac-2a–c) could be 
achieved with CaLB N435 in the high temperature range (rflow ›100 μmol/(h×g), E »200 and 
ee(R,R)-3a–c ›99.9% at and above 60°C), CaLB N435 was selected as biocatalyst to perform 
flow mode KR at preparative scale. The temperature was chosen to be 50–60°C where CaLB 
N435 has proved to be both productive and selective without the danger of losing its activity. 
For all the three substrates (rac-2a–c) the same series of six CaLB N435-filled columns 
was used. Between the runs with different substrates the columns were washed briefly with 
hexane–tert-butyl methyl ether (2:1) with about ten times the dead volume of the bioreactor to 
remove substrate residues. After 24 h of continuous-flow operation at 50°C, the bioreactor 
was switched to recirculation-flow mode at 60°C until the conversion reached nearly 50% or 
the ee(R,R)-3a-c (monitored by GC) started to decrease. The obtained (R,R)-acetates [(R,R)-3a–c] 
and (S,S)-alcohols [(S,S)-2a–c] were separated by column chromatography and the acetates 
[(R,R)-3a–c] were deacylated by Zemplén deacylation to yield the (R,R)-alcohols [(R,R)-2a–
c]  (Table 2). In most of the cases, high enantiomeric excesses values were observed; (R,R)-
3a–c, ›99.0%; (R,R)-2a–c, ›97–98%  and (S,S)-2b–c, ›93–94%. Only with (S,S)-2a was ee(R,R)-
2a ‹90.0%. 
 
Table 2. Alcohols prepared by kinetic resolution of rac-2a–c with vinyl acetate in a CaLB N435-filled continuous-flow 
reactor at preparative scale followed by Zemplén deacylation of the formed (R,R)-3a–c. 
Compound Yield (%) ee (%)
a
 [ ] 
    b  
(R,R)-2a  36
c
 97.8 +0.86 
(S,S)-2a 39 87.9 –0.75 
(R,R)-2b  33
c
 98.1 +0.17 
(S,S)-2b 34 94.8 –0.07 
(R,R)-2c  35
c
 98.7 +0.47 
(S,S)-2c 33 93.1 –0.19 
(R,R)-3a 45 99.1 +12.7 
(R,R)-3b 43 99.5 +10.7 
(R,R)-3c 42 99.2 +11.8 
a Enantiomeric excess was determined by chiral GC (see Section 4.2). 
b Specific rotations, (c 1.0, CH2Cl2). 
c Combined yield of kinetic resolution and Zemplén deacylation. 
 
During these runs, the CaLB N435-filled columns were used for more than three weeks in 
total. After all the continuous- and recirculation-flow runs with the three different substrates 
(rac-2a–c), testing of the spent CaLB N435-filled columns by KR of the unsubstituted 2-(1-
indolyl)cyclohexanol (rac-2a), between 30–60°C, indicated no observable change in activity 
or selectivity compared to the first single column tests (Figure 2). 
3. Conclusion 
Batch and continuous-flow methods were investigated for the first time for the lipase-
catalysed kinetic resolution of trans-1-(2-hydroxycyclohexyl)-indoles (rac-2a–c) by 
acetylation with vinyl acetate. The substrates rac-2a–c could be obtained conveniently by ring 
opening of cyclohexene oxide with the corresponding indole (1a–c). We studied the influence 
of temperature effect on productivity and selectivity in the 0–70°C range and found that a 
number of the thermostable biocatalysts produced higher productivity with excellent 
enantiomer selectivity in the continuous-flow KRs of rac-2a–c in the high temperature range 
(50–70°C) than at low temperatures. Based on this observation, highly enantiomerically 
enriched alcohols (2a–c) and acetates (3a–c) were produced by flow mode methods at 
preparative scale by using a CaLB N435 filled reactor operating at 50–60°C. 
4. Experimental 
4.1. Materials 
All chemicals and starting materials were purchased from Sigma-Aldrich (Saint Louis, 
MO, USA) and Alfa Aesar Europe (Karlsruhe, Germany) and used without further 
purification. 
Prior to use, solvents from Merck KGaA (Darmstadt, Germany) were dried and/or freshly 
distilled. 
Amano A (lipase from Aspergillus niger), Amano AK (lipase from Pseudomonas 
fluorescens), Amano AYS (lipase from Candida rugosa), Amano F-AP15 (lipase from 
Rhizopus oryzae), Amano G (lipase from Penicillium camamberti), Amano M (lipase from 
Mucor javanicus), Amano PS (lipase from Burkholderia cepacia), CrL (lipase from Candida 
rugosa), Lipozyme
®
 MmL (Lipozyme MmL, lipase from Mucor miehei, immobilized on 
macroporous ion-exchange resin), Lipozyme
®
 TLIM (Lipozyme
 
TLIM, lipase from 
Thermomyces lanuginosus, immobilized on ion-exchange resin), Novozym
®
 435 (CaLB 
N435, lipase B from Candida antarctica, adsorbed on acrylic resin) and PPL (lipase from 
porcin pancreas) were purchased from Sigma Aldrich (Saint Louis, MO, USA). CaLA T2-150 
(lipase A from Candida antarctica, covalently attached to dry acrylic beads of 150-300 µm 
particle size) and CaLB T2-150 (lipase B from Candida antarctica, covalently attached to dry 
acrylic beads of 150-300 µm particle size) were the products of ChiralVision BV (Leiden, 
The Netherlands). Lipobond PS (liase from Burkholderia cepacia, covalently immobilized on 
a highly hydrophobic support) was obtained from Iris Biotech GmbH (Marktredwitz, 
Germany). AK Dv250P (lipase from Pseudomonas fluorescens, adsorbed on phenyl-
functionalized silica gel), CaLA Dv250P (lipase from Candida antarctica, adsorbed on 
phenyl-functionalized silica gel), CaLB Dv250P (lipase from Candida antarctica, adsorbed 
on phenyl-functionalized silica gel), CrL Dv250O (lipase from Candida rugosa, adsorbed on 
octyl-functionalized silica gel), MpL Dv250O (lipase from Malbranchea pulchella, adsorbed 
on octyl-functionalized silica gel), MpL Dv250P (lipase from Malbranchea pulchella, 
adsorbed on phenyl-functionalised silica gel), PaL Dv250P (lipase from Pseudozyma aphidis, 
adsorbed on phenyl-functionalised silica gel) and PS Dv250O (lipase from Burkholderia 
cepatia, adsorbed on octyl-functionalized silica gel) were the products of SynBiocat Ltd. 
(Budapest, Hungary). 
4.2. Methods 
TLC was carried out using Kieselgel 60 F254 (Merck) sheets. Spots were visualized under 
UV light (254 nm and 365 nm) or by treatment with 5% ethanolic phosphomolybdic acid 
solution and heating of the dried plates. Optical rotations were taken on a Perkin-Elmer 241 
polarimeter that was calibrated by measuring the optical rotations of both enantiomers of 
menthol. The NMR spectra were recorded in CDCl3 on a Bruker DRX-300 spectrometer 
operating at 300 MHz for 
1
H and 75 MHz for 
13
C, and signals are given in ppm on the δ scale. 
Infrared spectra were recorded on a Bruker ALPHA FT-IR spectrometer and wavenumbers of 
bands are listed in cm
-1
. 
Reactions were analysed by GC on an Agilent 5890 equipment using Hydrodex β-TBDAc 
column (Machery-Nagel; 25 m × 0.25 mm × 0.25 µm, heptakis-(2,3-di-O-acetyl-6-O-t-butyl-
dimethylsilyl)-β-cyclodextrin) [FID (250°C), injector (250°C), H2 (12 psi, split ratio: 1:50)]. 
GC data [(oven program); tr (min)]: for 2a and 3a [(100–190°C, 9°C/min, 15 min at 190°C), 
(S,S)-3a: 18.9, (R,R)-3a: 19.4, (S,S)-2a: 21.1, (R,R)-2a: 21.6]; for 2b and 3b [(100–190°C, 
9°C/min, 20 min at 190°C); (S,S)-3b: 20.9, (R,R)-3b: 21.4, (S,S)-2a: 24.9, (R,R)-2a: 25.5]; for 
2c and 3c [(45 min at 190°C); (S,S)-3c: 30.9, (R,R)-3c: 32.0, (S,S)-2c: 37.2, (R,R)-2c: 38.2]. In 
Figures 2–4, data points are shown only for cases with ee ›98.0%. The solid curves and filled 
markers indicate data which arose from a precise integration of chromatograms in which both 
enantiomers of the products 3a–c were clearly visible. When signals for the minor enantiomer 
[(S,S)-3a–c] were indistinguishable from noise, the dashed lines and unfilled markers indicate 
values which are possible minimum values of ee and E. 
Conversion (c), enantiomeric excess (ee) and enantiomeric ratio (E) were determined by 
GC. Enantiomeric ratio (E) was calculated from c and enantiomeric excess of the product 
(eeP) using the equation E = ln[1 − c(1+eeP)]/ln[1 − c(1 − eeP)].
68
 For simplicity, E values 
calculated in the range of 100–200 were given as ›100, those in the range of 200–500 as ›200 
and above 500 as »200. To characterize the productivity of the biocatalysts, specific reaction 
rates in batch reactions (rbatch) were calculated using the equation rbatch = nP/(t × mB) (where nP 
[µmol] is the amount of the product, t [h] is the reaction time and mB [g] is the mass of the 
applied biocatalyst).
65
 Specific reaction rates in continuous-flow systems (rflow) were 
calculated using the equation rflow =  [P]  × v/mB (where [P] [µmol/mL] is the molar 
concentration of the product, v [mL/h] is the flow rate and mB [g] is the mass of the applied 
biocatalyst).
65
 Because the rate of product formation is not a linear function of c, rigorous 
comparisons between the productivity of a continuous-flow reaction and its batch mode 
counterpart using their r values can only be made at comparable degrees of conversions.
65
 
Continuous-flow kinetic resolutions were performed in a laboratory flow reactor 
comprising an isocratic HPLC pump (Knauer K-120) attached to stainless steel columns 
(ThalesNano CatCart
TM
) filled with the immobilized lipase biocatalysts in an in-house made 
thermostated aluminium metal block multicolumn holder with precise temperature control 
(Figure 1). Before use, the lipase-filled columns were washed with a 2:1 mixture of hexane 
and tert-butyl methyl ether (0.5 mL/min, 20 min). 
Enzymes were filled into stainless steel CatCart
TM
 columns according to the process of 
ThalesNano Inc. For the continuous-flow enzymatic applications both ends of the columns 
were sealed with PTFE sealings and silver metal filter membranes (Sterlitech Silver 
Membrane Filter from Sigma–Aldrich, Z623237, pore size 0.45 µm; pure metallic silver, 
99.97% with no extractable or detectable contaminants). 
4.3. Synthesis of racemic secondary alcohols (rac-2a–c) 
Secondary alcohols were obtained by a slightly modified method of Gharpure, J. S. and 
Sathiyanarayanan, A. M.
67
 A solution of the indole (1a: 0.854 mol, 1b: 0.381 mol, 1c: 0.340 
mol) in dry DMF (40 mL) was added dropwise to a stirred suspension of NaH (1 equiv.) in 
dry DMF (60 mL) at 0°C over 15 min. After stirring at 0°C for 20 min, cyclohexene oxide (1 
equiv.) was added and the resulting slurry was allowed to warm to room temperature and 
stirred overnight. Then the reaction mixture was stirred under reflux. When the reaction was 
completed (monitored by TLC, eluent: CH2Cl2), it was cooled, quenched by water (50 mL) 
and extracted with diethyl ether (3×50 mL). The combined organic phases were washed with 
brine (2×50 mL), dried over Na2SO4 and the solvent was removed under vacuum. The residue 
was further purified by column chromatography on silica gel eluted with CH2Cl2. 
rac-2a: 17.82 g (97%), pale yellow crystals, mp: 85.2–86.0°C, IR (KBr, cm-1): ν 3238, 
3098, 2929, 2848, 1717, 1507, 1461, 1311, 1215, 1090, 739; 
1
H NMR: 1.38–1.57 (2H, m, 
CH2), 1.76–1.93 (4H, m, CH2), 2.03–2.10 (1H, m, CH2), 2.17–2.24 (1H, m, CH2), 3.88 (1H, 
td, J=9.80 and 4.14 Hz, O-CH), 4.11 (1H, td, J=9.23 and 3.96 Hz, N-CH), 5.32 (1H, s, OH), 
6.60 (1H, d, J=2.83 Hz, CH), 7.11–7.28 (3H, m, CH), 7.50 (1H, d, J=8.29 Hz, CH), 7.66 (1H, 
d, J=7.24 Hz, CH); 
13
C NMR: 24.55 (CH2), 25.66 (CH2), 32.02 (CH2), 33.82 (CH2), 62.19 
(CH), 73.89 (CH), 102.63 (CH), 110.07 (CH), 119.83 (CH), 121.19 (CH), 121.83 (CH), 
124.18 (CH), 128.67 (C), 136.98 (C). 
rac-2b: 8.08 g (92%), pale yellow crystals, mp: 91.1–92.9°C, IR (KBr, cm-1): ν 3293, 
2929, 2851, 1755, 1612, 1553, 1464, 1357, 1224, 1204, 1086, 1015, 943, 735; 
1
H NMR: 
1.39–1.55 (2H, m, CH2), 1.65–1.92 (4H, m, CH2), 2.00–2.08 (1H, m, CH2), 2.16–2.25 (1H, m, 
CH2). 2.34 (3H, s, CH3), 3.80–3.92 (1H, m, O-CH), 3.99–4.10 (1H, m, N-CH), 5.30 (1H, s, 
OH), 6.99 (1H, s, CH), 7.08–7.16 (1H, m, CH), 7.17–7.25 (1H, m, CH), 7.43 (1H, d, J=8.23 
Hz, CH), 7.58 (1H, d, J=7.91 Hz, CH); 
13
C NMR: 9.94 (CH3), 24.60 (CH2), 25.73 (CH2), 
32.06 (CH2), 33.76 (CH2), 61.97 (CH), 73.93 (CH), 109.83 (C), 111.92 (CH), 119.17 (CH), 
119.28 (CH), 121.72 (CH), 121.85 (CH), 128.91 (C), 137.34 (C). 
rac-2c: 8.18 g (98%), yellow oil, IR (film, cm
-1
): ν 3270, 2933, 2856, 1620, 1479, 1448, 
1233, 1151, 1067, 1030, 948, 792, 712; 
1
H NMR: 1.37–1.52 (2H, m, CH2), 1.73–1.91 (4H, m, 
CH2), 2.05 (1H, m, CH2), 2.19 (1H, m, CH2), 3.82–3.89 (4H, m, O-CH3 and O-CH), 3.97–
4.07 (1H, m, N-CH), 5.31 (1H, s, OH), 6.46–6.54 (1H, m, CH), 6.86–6.93 (1H, m, CH), 7.08–
7.13 (1H, m, CH), 7.15–7.20 (1H, m, CH), 7.36 (1H, d, J=8.85 Hz, CH); 13C NMR: 24.55 
(CH2), 25.67 (CH2), 32.02 (CH2), 33.81 (CH2), 56.08 (CH3), 62.44 (CH), 73.98 (CH), 102.18 
(CH), 102.72 (CH), 110.81 (CH), 112.24 (CH), 124.77 (CH), 128.97 (C), 132.26 (C), 154.33 
(C). 
4.4. Synthesis of racemic acetates (rac-3a–c) 
To a mixture of the corresponding alcohol (2a: 1.39 mmol, 2b: 1.31 mmol, 2c: 1.22 mmol) 
in acetic anhydride (2 mL), catalytic amount (1 drop) of cc. H2SO4 was added at room 
temperature and the resulting slurry was stirred for 1 min (the reaction completed by TLC). 
After adding hexane (5 mL) to the mixture, it was washed with 10% Na2CO3 (3×5 mL) and 
brine (5 mL), the organic phase was dried over Na2SO4 and the solvent was removed under 
vacuum. No further purification was necessary. 
rac-3a: 83 mg (23%), white crystals, mp: 63.3–65.2°C, IR (KBr, cm-1): ν 3045, 2939, 
2860, 1748, 1607, 1510, 1475, 1460, 1373, 1314, 1229, 1034, 745; 
1
H NMR: 1.41–1.67 (3H, 
m, CH2), 1.81–2.03 (3H, m, CH2), 2.11–2.27 (2H, m, CH2), 4.26–4.36 (1H, m, N-CH), 5.07–
5.21 (1H, m, O-CH), 6.54–6.56 (1H, m, CH), 7.05–7.15 (1H, m, CH), 7.17–7.30 (2H, m, CH), 
7.44 (1H, d, J=8.28 Hz, CH), 7.62 (1H, d, J=7.89 Hz, CH); 
13
C NMR: 20.47 (CH3), 24.41 
(CH2), 25.40 (CH2), 31.97 (CH2), 32.15 (CH2), 58.23 (CH), 75.04 (CH), 102.31 (CH), 109.83 
(CH), 119.47 (CH), 121.08 (CH), 121.37 (CH), 124.14 (CH), 128.50 (C), 136.94 (C), 170.08 
(CO). 
rac-3b: 101 mg (28%), brown crystals, mp: 78.4–80.1°C, IR (KBr, cm-1): ν 3061, 2939, 
2861, 1739, 1613, 1463, 1452, 1359, 1297, 1235, 1125, 1031, 739; 
1
H NMR: 1.43–1.60 (3H, 
m, CH2, CH3), 1.78–1.95 (3H, m, CH2), 2.07–2.22 (2H, m, CH2), 2.30 (3H, s, CH3), 4.18–
4.28 (1H, m, N-CH), 5.02–5.11 (1H, m, O-CH), 6.94 (1H, s, CH), 7.07 (1H, t, J=7.74 Hz, 
CH), 7.18 (1H, t, J=7.16 Hz, CH), 7.36 (1H, d, J=8.29 Hz, CH), 7.52 (1H, d, J=7.91 Hz, CH);
 
13
C NMR: 9.95 (CH3), 20.88 (CH3), 24.44 (CH2), 25.43 (CH2), 31.98 (CH2), 32.25 (CH2), 
57.96 (CH), 75.12 (CH), 109.65 (CH), 111.35 (C), 118.74 (CH), 119.06 (CH), 121.30 (CH), 
121.64 (CH), 128.74 (C), 137.30 (C), 170.22 (CO). 
rac-3c: 59 mg (17%), white crystals, mp: 70.3–72.8°C, IR (KBr, cm-1): ν 2997, 2938, 
2855, 1732, 1618, 1484, 1453, 1376, 1254, 1233, 1157, 1125, 1033, 796, 717; 
1
H NMR: 
1.42–1.63 (3H, m, CH2), 1.82–1.99 (3H, m, CH2), 2.09–2.25 (2H, m, CH2), 3.85 (3H, s, CH3), 
4.14–4.29 (1H, m, N-CH), 5.01–5.16 (1H, m, O-CH), 6.46 (1H, s, CH), 6.87 (1H, d, J=9.0 
Hz, CH), 7.07 (1H, s, CH), 7.16 (1H, s, CH), 7.31 (1H, d, J=9.0 Hz, CH);
 13
C NMR: 20.65 
(CH3), 24.24 (CH3), 25.23 (CH2), 31.77 (CH2), 31.96 (CH2), 55.85 (CH2), 58.29 (CH), 74.99 
(CH), 101.69 (CH), 102.33 (C), 110.42 (CH), 111.65 (CH), 124.51 (CH), 128.54 (CH), 
132.12 (C), 153.86 (C), 169.91 (CO). 
4.5. Enantiomer selective acetylation of racemic alcohols (rac-2a–c) in batch mode 
To a solution of the alcohol (25 mg, rac-2a–c) in hexane–tert-butyl methyl ether–vinyl 
acetate 6:3:1 (2 mL) in an amber screw cap vial, the enzyme (25 mg) was added and the 
mixture was shaken (1000 rpm) in the closed vial at 30°C for 72 h. Samples (50 µL, diluted 
with CH2Cl2 to 300 µL) were taken directly from the reaction mixture after 1, 4, 8, 24, 48 and 
72 h and analysed by GC as described in Section 4.2. 
4.6. Enantiomer selective acetylation of racemic alcohols (rac-2a–c) in continuous-
flow bioreactors 
Separate CatCart
TM
 columns were packed for each substrate (rac-2a–c) in this study 
[filling weights: for KRs of rac-2a (CaLA Dv250P: 202 mg, CaLB N435: 256 mg, Lipozyme 
TLIM: 290 mg, Amano AK: 411 mg, Lipobond PS: 307 mg and Lipozyme MmL: 250 mg); 
for KRs of rac-2b (CaLB N435: 237 mg, Lipozyme TLIM: 286 mg, Lipobond PS: 276 mg 
and Lipozyme MmL: 233 mg); for KRs of rac-2c (CaLB N435: 224 mg, Lipozyme TLIM: 
301 mg; Lipobond PS: 280 mg and Lipozyme MmL: 245 mg)]. 
The alcohol (5 mg/mL, rac-2a–c) dissolved in a 6:3:1 mixture of hexane–tert-butyl methyl 
ether–vinyl acetate was pumped through the enzyme-packed column thermostated at various 
temperatures (0–70°C) at a flow rate of 0.2 mL/min. Experiments were run in 10°C steps at 
temperatures of 0–70°C. Samples were collected after stationary operation has been 
established (sample size 100 µL, diluted with CH2Cl2 to 250 µL; taken 30 min after setting a 
new temperature) and analysed by GC as described in Section 4.2. Results for KRs of rac-2a–
c are shown in Figures 3–5, respectively. 
4.7. Kinetic resolution of racemic alcohols (rac-2a–c) in continuous-flow bioreactors 
at preparative scale 
A series of six serially-connected CaLB N435-filled CatCart
TM
 columns (total filling 
weight: 1373 mg) was used for the preparative scale kinetic resolutions of the substrates (rac-
2a–c). Before and after each run, the set of columns was flushed with a 2:1 mixture of 
hexane–tert-butyl methyl ether (0.5 mL/min, 1 h) and the washed columns were stored at 4°C. 
The solution of the alcohol (5 mg/mL of rac-2a–c) in a 6:3:1 mixture of hexane–tert-butyl 
methyl ether–vinyl acetate was pumped through the enzyme filled column series thermostated 
to 50°C at a flow rate of 0.15 mL/min. After collecting ~210 mL (24 h) of the reaction 
mixture the system was switched to recirculation at 60°C until the conversion reached ~45–
47%. To check the progress of the reaction, samples were collected (sample size 100 µL, 
diluted with CH2Cl2 to 250 µL) and analysed by GC as described in Section 4.2. 
After finishing the reaction (140–170 h) the solvent was removed under vacuum and the 
alcohol [(S,S)-2a–c] and acetate [(R,R)-3a–c] were separated by column chromatography on 
silica gel eluted with CH2Cl2. 
(S,S)-2a: 0.421 g (39%), white crystals, mp: 79.5–81.3°C, [ ] 
    = –0.75 (CH2Cl2), 
ee=87.9% by GC, IR (KBr, cm
-1
): ν 3427, 3050, 2928, 2856, 1610, 1512, 1463, 1411, 1312, 
1251, 1059, 947, 765, 738. 
(S,S)-2b: 0.367 g (34%), white crystals, mp: 74.8–76.1°C, [ ] 
    = –0.07 (CH2Cl2), 
ee=94.8% by GC, IR (KBr, cm
-1
): ν 3251, 3048, 2930, 2849, 1753, 1613, 1555, 1465, 1385, 
1357, 1225, 1206, 1128, 1085, 1015, 942, 805, 736. 
(S,S)-2c: 0.351 g (33%), yellow oil, [ ] 
    = –0.19 (CH2Cl2), ee=93.1% by GC, IR (film, 
cm
-1
): ν 3412, 2933, 2857, 1720, 1619, 1547, 1480, 1448, 1347, 1234, 1210, 1152, 1067, 
1032, 949, 793, 714. 
(R,R)-3a: 0.580 g (45%), pale yellow crystals, mp: 76.1–77.1°C, [ ] 
    = +12.7 (CH2Cl2), 
ee=99.0% by GC, IR (KBr, cm
-1
): ν 3467, 3055, 2935, 2859, 1923, 1742, 1610, 1556, 1510, 
1461, 1409, 1370, 1314, 1230, 1029, 868, 736, 713. 
(R,R)-3b: 0.549 g (43%), white oil, [ ] 
    = +10.7 (CH2Cl2), ee=99.5% by GC, IR (film, 
cm
-1
): ν 3049, 2937, 2861, 1734, 1612, 1461, 1360, 1297, 1232, 1195, 1033, 909, 736. 
(R,R)-3c: 0.531 g (42%), yellow crystals, mp: 65.1–66.1°C, [ ] 
    = +11.8 (CH2Cl2), 
ee=99.2% by GC, IR (KBr, cm
-1
): ν 2930, 2860, 1731, 1481, 1450, 1370, 1231, 1155, 1028, 
851, 795, 714. 
4.8. Zemplén deacetylation of acetates [(R,R)-3a–c] 
To a solution of (R,R)-3a–c (0.50 g) dissolved in dry methanol (10 mL) 0.1 equiv. of 
CH3ONa was added at 0°C. The resulting solution was stirred at 0°C for 1.5 h then at room 
temperature until the completion of the reaction (14–18 h, monitored by TLC using CH2Cl2 as 
eluent). After removing the solvent under vacuum the residue was filtered through a thin layer 
of silica gel by eluting with a 20:1 mixture of CH2Cl2 and CH3OH. 
(R,R)-2a: 0.339 g (81%), pale yellow crystals, mp: 85.9–86.7°C, [ ] 
    = +0.86 (CH2Cl2), 
ee=97.8% by GC, IR (film, cm
-1
): ν 3387, 2933, 2856, 1508, 1477, 1459, 1410, 1309, 1209, 
1065, 948, 869, 735. 
(R,R)-2b: 0.321 g (76%), pale yellow oil, [ ] 
    = +0.17 (CH2Cl2), ee=98.1% by GC, IR 
(film, cm
-1
): ν 3406, 2932, 2857, 1612, 1460, 1357, 1218, 1191, 1066, 1030, 944, 733. 
(R,R)-2c: 0.359 g (84%), yellow oil, [ ] 
    = +0.47 (CH2Cl2), ee=98.7% by GC, IR (film, 
cm
-1
): ν 3421, 2933, 2857, 1620, 1479, 1448, 1234, 1151, 1067, 1031, 949, 792, 714. 
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Table 1. Lipase-catalysed kinetic resolution of secondary alcohols (rac-2a–c) by acylation with vinyl acetate in batch mode 
(30°C, shake flask). 
Entry Substrate Enzyme c (%)
a
 ee(R,R)-3a (%)
b
 E
c
 rbatch (µmol g
-1
 h
-1
) 
Panel A
d
      
1 rac-2a CaLB N435 49.9 ›99.9 »200 32.6 
2 rac-2a Lipobond PS 47.2 ›99.9 »200 30.8 
3 rac-2a Lipozyme TLIM 40.2 ›99.9 »200 26.2 
4 rac-2a Lipozyme MmL 38.7 ›99.9 »200 25.3 
5 rac-2a Amano AK 37.0 ›99.9 »200 24.1 
6 rac-2a CaLA G250P 25.1 99.8 »200 16.4 
7 rac-2a CaLA T2-150 14.7 99.6 »200 9.6 
8 rac-2a MpL G250P 13.9 99.9 »200 9.0 
9 rac-2a MpL G250O 11.1 99.9 »200 7.2 
10 rac-2a CaLB G250P 9.4 99.9 »200 6.2 
11 rac-2a PaL G250P 8.6 99.8 »200 5.6 
Panel B
e
      
12 rac-2b CaLB N435 41.2 ›99.9 »200 37.6 
13 rac-2b Lipobond PS 27.7 ›99.9 »200 25.0 
14 rac-2b Lipozyme TLIM 27.4 ›99.9 »200 25.0 
15 rac-2b Lipozyme MmL 24.1 ›99.9 »200 21.7 
16 rac-2b CaLB G250P 12.9 99.9 »200 11.9 
17 rac-2b Amano AK 9.0 99.9 »200 8.1 
18 rac-2b Amano M 6.5 99.9 »200 5.9 
19 rac-2b Amano PS 5.5 99.8 »200 5.0 
Panel C
e
      
20 rac-2c Lipozyme TLIM 44.9 ›99.9 »200 38.6 
21 rac-2c CaLB N435 38.7 ›99.9 »200 33.0 
22 rac-2c Lipozyme MmL 34.4 ›99.9 »200 29.1 
23 rac-2c Lipobond PS 33.5 ›99.9 »200 28.5 
24 rac-2c Amano AK 27.0 99.9 »200 22.8 
25 rac-2c CaLB G250P 13.7 99.9 »200 11.7 
26 rac-2c CaLA G250P 10.6 99.9 »200 9.0 
27 rac-2c CrL 7.3 99.9 »200 6.2 
28 rac-2c Amano PS 7.2 99.8 »200 6.1 
29 rac-2c CaLA T2-150 6.9 99.8 »200 5.9 
a Results are shown only for reactions with c ›5%. 
b Enantiomeric excess of ester (ee(R,R)-3a–c) was determined by chiral GC. 
c Enantiomeric ratio (E) was calculated from c and ee(R,R)-3a–c.
68 For simplicity, E values calculated above 500  were given as 
»200. 
d Reaction time 72 h. 
e Reaction time 48 h. 
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Table 2. Alcohols prepared by kinetic resolution of rac-2a–c with vinyl acetate in a CaLB N435-filled continuous-flow 
reactor at preparative scale followed by Zemplén deacylation of the formed (R,R)-3a–c. 
Compound Yield (%) ee (%)
a
 [ ] 
    b  
(R,R)-2a  36
c
 97.8 +0.86 
(S,S)-2a 39 87.9 –0.75 
(R,R)-2b  33
c
 98.1 +0.17 
(S,S)-2b 34 94.8 –0.07 
(R,R)-2c  35
c
 98.7 +0.47 
(S,S)-2c 33 93.1 –0.19 
(R,R)-3a 45 99.1 +12.7 
(R,R)-3b 43 99.5 +10.7 
(R,R)-3c 42 99.2 +11.8 
a Enantiomeric excess was determined by chiral GC (see Section 4.2). 
b Specific rotations, (c 1.0, CH2Cl2). 
c Combined yield of kinetic resolution and Zemplén deacylation. 
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